The Global Center for Medical Innovation (GCMI) and the Atlantic Pediatric Device Consortium (APDC) are partnering this year to bring together core members of the medical device community to accelerate the commercialization of innovative medical technology. The GCMI APDC Medtech Innovation Education Series is designed to provide creative clinicians and researchers with an overview of the commercialization process and a forum to discuss and share ideas with experienced medtech innovators and entrepreneurs.

Mark your calendar and look for more information on our websites.  We encourage you to attend each session as we cover everything from concept development to funding. We will email updates and registration details throughout the year.

Session 2:  Managing Early Stage Intellectual Property (Register HERE)

Our second session will provide an overview of intellectual property (IP) and highlight best practices to consider throughout the device development process. Attendees will interact with and hear “lessons learned” from legal experts and industry executives. The panelists for this session are:

• Miles Hall, DVM, Principal, Meunier, Carlin & Curfman, LLC
• Collen Beard, Partner, Parks IP Law, LLC
• Noah Roth, Director of IP and New Technology, ICON Interventional Systems, Inc.

These Thursday evening sessions will begin with a networking session at 5:15pm followed by presentations by leading experts in these areas.  Registration will be posted as soon as available for each session.

Info on final two sessions:

Sept 25, 2014   
Session 3:  Regulatory Issues and Quality in Development
Even during early product development, innovators must think about regulatory issues and design control for quality assurance.  Regulatory, engineering, manufacturing, and quality teams must work together, early and often.  This session will provide an opportunity to hear experts in these areas will explore best practices and expectations for incorporating these areas into your development and planning process.

Nov 20, 2014   
Session 4:  Funding and Exit Strategies
Our final session will address funding & exit strategies, including perspectives from venture capital, acquisitions, angel funding and federal grants.